Quantcast
Home > Quotes > KLDO

Kaleido Biosciences, Inc. Common Stock (KLDO) Quote & Summary Data

KLDO 
$9.5816
*  
1.2716
15.3%
Get KLDO Alerts
*Delayed - data as of Jan. 29, 2020 10:59 ET  -  Find a broker to begin trading KLDO now
Exchange:NASDAQ
Industry: Health Care
View:    KLDO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 9.59 / $ 9.65
1 Year Target
17.25
Today's High / Low
$ 9.82 / $ 8.381
Share Volume
90,451
50 Day Avg. Daily Volume
193,225
Previous Close
$ 8.31
52 Week High / Low
$ 19 / $ 4.61
Market Cap
288,047,281
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1

Intraday Chart

Shares Traded

Share Volume:
90,451
50 Day Avg. Daily Volume:
193,225

Trading Range

The current last sale of $9.5816 is 107.84% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.82 $ 19
 Low: $ 8.381 $ 4.61

Company Description (as filed with the SEC)

We are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health. We have built a human-centric proprietary product platform for discovery and development that we believe will enable the rapid advancement of a broad portfolio of novel product candidates into non-IND human clinical studies under regulations supporting research with food. Our product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. We have an industrialized approach to the discovery and development of MMTs, and our initial MMTs are targeted glycans. Each targeted glycan is an ensemble of complex carbohydrates that is intended to modulate microbial metabolism to drive a specific biological response.  ... More ...  



Risk Grade

Where does KLDO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.51
Open Date:
Jan. 29, 2020
Close Price:
N/A
Close Date:
N/A


Consensus Recommendation

Analyst Info